• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • David Watson, Scotland

    David Watson, Scotland

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • David Hall, USA

    David Hall, USA

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Rosie Riley, USA

    Rosie Riley, USA

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Frank Taylor, USA

    Frank Taylor, USA

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Lee Millard, England

    Lee Millard, England

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Lombana, Spain

    Lombana, Spain

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Sally Pauls, USA

    Sally Pauls, USA

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Timmy, Belgium

    Timmy, Belgium

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Zabun Nassar, England

    Zabun Nassar, England

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Mike Small, UK

    Mike Small, UK

  • Dick Dayton, USA

    Dick Dayton, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login